# Personalized Prediction of Tolerance and Immunogenicity in Hemophilia

> **NCT01626105** · — · UNKNOWN · sponsor: **Victor J Marder, M.D.** · enrollment: 55 (estimated)

## Conditions studied

- Hemophilia A

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01626105
- **Lead sponsor:** Victor J Marder, M.D.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2013-04
- **Final completion:** 2014-06
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2012-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01626105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01626105, "Personalized Prediction of Tolerance and Immunogenicity in Hemophilia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01626105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*